Captopril
Who holds supplier records for Captopril? 7 organisations hold a current record for Captopril: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (3), Spain (3) and India (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Captopril: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/captopril
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Captopril. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Wockhardt LimitedIndiaCEP Company GMP cert on recordActive DMF 8028 · latest filing Apr 1989
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 14311 · latest filing Jul 1999
- Zhongfu Pharmaceutical Co., Ltd.ChinaCEPActive DMF 11905 · latest filing Mar 1996
- CHANGZHOU PHARMACEUTICAL FACTORYChina Company GMP cert on recordActive DMF 33888 · latest filing May 2019
- MEDICHEM SASpain Company GMP cert on recordActive DMF 9770, 32247 · latest filing Dec 2017
- QUIMICA SINTETICA SASpain Company GMP cert on recordActive DMF 8460 · latest filing Mar 1990
- FARMHISPANIA SASpainCEPInactive DMF 9269 · latest filing Jul 1991
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Captopril, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | R1-CEP 1997-023 - Rev 10 Captopril | Oct 2020 | — |
| ZHONGFU PHARMACEUTICAL CO., LTD. Weifang City | CN | R1-CEP 2003-113 - Rev 02 Captopril | Oct 2016 | — |
| Wockhardt Limited Mumbai | IN | R1-CEP 1998-052 - Rev 04 Captopril | Jun 2014 | — |
| Farmhispania, S.A. Montmeló | ES | R1-CEP 1997-018 - Rev 06 Captopril | Mar 2011 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Captopril are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- SINOVA PHARMACEUTICALS CO PTE LTDInactive DMF 12672 · filed Sept 1997
- BORYUNG PHARMACEUTICAL CO LTDInactive DMF 11228 · filed Dec 1994
- SHANDONG WEI FANG PHARMACEUTICAL FACTORYInactive DMF 9745 · filed Jun 1992
- Hungary · Inactive DMF 9221 · filed Jul 1991
Overview
Captopril is an angiotensin-converting enzyme (ACE) inhibitor used primarily for the treatment of hypertension and certain types of heart failure. It works by relaxing blood vessels and reducing blood pressure, improving blood flow and oxygen supply to the heart.
Chemical identity
- IUPAC name
- (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
- Canonical SMILES
- C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O
- InChIKey
- FAKRSMQSSFJEIM-RQJHMYQMSA-N
- Synonyms
- Capoten API, apopril, c09aa01, capoten, captomax, captoprilum, farcopril, garranil, hypopress, mepha, nsc-757419, sa-333
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Angiotensin Converting Enzyme Inhibitor
- Mechanism of action
- Angiotensin-converting Enzyme Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Captopril?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Captopril: Wockhardt Limited (India), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), Zhongfu Pharmaceutical Co., Ltd. (China), CHANGZHOU PHARMACEUTICAL FACTORY (China), MEDICHEM SA (Spain), QUIMICA SINTETICA SA (Spain) and FARMHISPANIA SA (Spain). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Captopril Drug Master Files are active?
Wockhardt Limited (DMF 8028), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 14311), Zhongfu Pharmaceutical Co., Ltd. (DMF 11905), CHANGZHOU PHARMACEUTICAL FACTORY (DMF 33888), MEDICHEM SA (DMF 9770, 32247) and QUIMICA SINTETICA SA (DMF 8460). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Captopril records mean?
4 organisations have only inactive Type II DMFs for Captopril. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Captopril have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Captopril on the EDQM register, including ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai (CN), ZHONGFU PHARMACEUTICAL CO., LTD. Weifang City (CN), Wockhardt Limited Mumbai (IN) and Farmhispania, S.A. Montmeló (ES). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Captopril supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Captopril?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.